WebJun 18, 2024 · In June 2024, new data emerged that require reevaluation of these recommendations. The OlympiA phase III, double-blind, randomized trial reported on the efficacy and safety of adjuvant PARP inhibitor therapy with olaparib in patients with early-stage, (HER2)-negative breast cancer with high risk of recurrence and pathogenic … WebThis prestigious award is selected by the SSO President and is given to an individual whose work has impacted the clinical practice of surgical oncology. The recipient presents a lecture at the SSO Annual Cancer Symposium in the year they are awarded. Selwyn M. Vickers, MD, FACS 2024 Suzanne L. Topalian, MD 2024 Jatin P. … John Wayne Clinical …
Use of letrozole after aromatase inhibitor-based therapy in ...
WebApr 3, 2024 · The ASCO, ASTRO, and SSO Guideline on the Management of Hereditary Breast Cancer provides important information and clearly needed guidance on the optimal surgical, radiation, and systemic therapy management of breast cancer patients with germline mutations in breast cancer susceptibility genes. This information and … WebFeb 6, 2013 · Eleftherios (Terry) P. Mamounas, MD, MPH, from the Aultman Hospital Cancer Center, discusses the controversial topic of surgery for patients who present with … proximal arch aorta
2024 SABCS Public Friday - SABCS
WebFeb 3, 2024 · Eleftherios P. Mamounas, MD. Associate Professor of Surgery, Northeastern Ohio Universities College of Medicine, Rootstown, Ohio; Medical Director, Aultman Cancer Center, Canton, Ohio Disclosures. Disclosure: Eleftherios Mamounas, MD, MPH, FACS, has disclosed that he has received grants for educational research from Sanofi-Aventis … WebEleftherios Mamounas, MD is a Surgeon in Orlando, FL. Eleftherios Mamounas, MD does not participate in Zocdoc to offer online booking at this time. Dr. Michael Jacoby , … WebDr. Eleftherios Mamounas, MD is a General Surgery Specialist in Orlando, FL. They specialize in General Surgery, has 40 years of experience. They graduated from … proximal artery occlusion